James Lankford actually said...

"I have people in this study that are terminal, and that you are allowing the study to be able to go through, to the end, when you see an obvious effect."

"When the first level is done and patients hear the stories--or people that are not patients hear the stories--this seems to be effective, but then there is the pause to say, 'We are going to go throug..."

"I am concerned that the FDA has a requirement and that they are trying to fulfill that requirement to be able to get the drug to market, but that it may inadvertently doom some child or some adult to ..."

"There is a difference between effective and duplicative."